Evidence map›Paper›PMID 36271889›Full record

ReviewImmunological reviews2023

C3-dependent effector functions of complement.

Alessandra Zarantonello, Margot Revel, Anne Grunenwald, Lubka T Roumenina

Open access · bronzeAbstract readReview
In one paragraph

Review in Immunological reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
8.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Immune dysregulation and epileptogenesis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Liposomes in tumor treatment: a double-edged sword.Science China. Life sciences · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Immune Predictors of Radiotherapy Outcomes in Cervical Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alessandra ZarantonelloCentre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.
Margot RevelCentre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.
Anne GrunenwaldCentre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.
Lubka T RoumeninaCentre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.ORCID 0000-0002-9940-0324
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

C3 is the central effector molecule of the complement system, mediating its multiple functions through different binding sites and their corresponding receptors. We will introduce the C3 forms (native C3, C3 [H

Indexed as

Complement C3Complement C3bBinding SitesComplement ActivationHumansReceptors, ComplementComplement C3Complement C3bReceptors, Complementanaphylatoxinautoimmunitycancercomplement C3inflammationopsonin

Identifiers

PMID36271889
PMCPMC10092904
OpenAlexW4307090693

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.